Affimed (AFMD) News Today $2.72 -0.28 (-9.33%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?November 19 at 8:53 PM | msn.comCantor Fitzgerald Reiterates "Overweight" Rating for Affimed (NASDAQ:AFMD)Cantor Fitzgerald reaffirmed an "overweight" rating on shares of Affimed in a report on Tuesday.November 19 at 9:43 AM | marketbeat.comAffimed's (AFMD) "Buy" Rating Reiterated at HC WainwrightNovember 18 at 1:35 AM | americanbankingnews.comAffimed (NASDAQ:AFMD) Price Target Lowered to $4.00 at Stifel NicolausNovember 17, 2024 | americanbankingnews.comPromising Clinical Developments and Data Catalysts Position Affimed for Strong Future ProspectsNovember 17, 2024 | markets.businessinsider.comAffimed price target lowered to $4 from $5 at StifelNovember 17, 2024 | markets.businessinsider.comStifel Nicolaus Cuts Affimed (NASDAQ:AFMD) Price Target to $4.00Stifel Nicolaus cut their target price on Affimed from $5.00 to $4.00 and set a "hold" rating on the stock in a report on Friday.November 15, 2024 | marketbeat.comAffimed N.V. (NASDAQ:AFMD) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | insidermonkey.comHC Wainwright Reiterates Buy Rating for Affimed (NASDAQ:AFMD)HC Wainwright reiterated a "buy" rating and set a $10.00 price objective on shares of Affimed in a report on Friday.November 15, 2024 | marketbeat.comAffimed Faces Growing Losses Amid Financial StrugglesNovember 15, 2024 | markets.businessinsider.comAffimed N.V. (AFMD) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comAffimed Reports Third Quarter 2024 Financial Results & Business UpdateNovember 14, 2024 | globenewswire.comA Look Ahead: Affimed's Earnings ForecastNovember 13, 2024 | benzinga.comAffimed Q3 2024 Earnings PreviewNovember 13, 2024 | msn.comAffimed (AFMD) Set to Announce Earnings on ThursdayAffimed (NASDAQ:AFMD) will be releasing earnings before the market opens on Thursday, November 14, Zacks reports.November 7, 2024 | marketbeat.comAffimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024November 6, 2024 | globenewswire.comAffimed (NASDAQ:AFMD) Share Price Passes Above Fifty Day Moving Average - Time to Sell?Affimed (NASDAQ:AFMD) Stock Passes Above 50 Day Moving Average - Time to Sell?November 6, 2024 | marketbeat.comAffimed (NASDAQ:AFMD) Given Average Rating of "Buy" by AnalystsShares of Affimed (NASDAQ:AFMD - Get Free Report) have received a consensus rating of "Buy" from the four ratings firms that are presently covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a buy recommendation. The average 12-month target price among analysOctober 28, 2024 | marketbeat.com683 Capital Management, LLC Expands Stake in Affimed NVOctober 24, 2024 | gurufocus.comAffimed (NASDAQ:AFMD) Given Average Rating of "Buy" by BrokeragesAffimed (NASDAQ:AFMD - Get Free Report) has earned a consensus rating of "Buy" from the four research firms that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a buy rating. The average 12-month target price among brokerages that have issuOctober 3, 2024 | marketbeat.comTruist Financial Sticks to Its Buy Rating for Affimed (AFMD)September 24, 2024 | markets.businessinsider.comAffimed N.V. (A28A.F)September 11, 2024 | sg.finance.yahoo.comAffimed to Present at the Cantor Global Healthcare Conference 2024September 10, 2024 | globenewswire.comAffimed (NASDAQ:AFMD) Earns Overweight Rating from Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating on shares of Affimed in a report on Monday.September 9, 2024 | marketbeat.comAffimed (NASDAQ:AFMD) Receives Average Rating of "Buy" from AnalystsShares of Affimed (NASDAQ:AFMD - Get Free Report) have received a consensus recommendation of "Buy" from the four ratings firms that are covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers thaSeptember 8, 2024 | marketbeat.comAffimed N.V. (NASDAQ:AFMD) Q2 2024 Earnings Call TranscriptSeptember 7, 2024 | msn.comBuy Rating Justified by Promising Clinical Data and Solid Progress in Affimed’s Drug DevelopmentsSeptember 6, 2024 | markets.businessinsider.comHC Wainwright Reiterates "Buy" Rating for Affimed (NASDAQ:AFMD)HC Wainwright reiterated a "buy" rating and set a $10.00 target price on shares of Affimed in a report on Friday.September 6, 2024 | marketbeat.comAffimed Reports Second Quarter 2024 Financial Results & Business UpdateSeptember 5, 2024 | markets.businessinsider.comAffimed N.V. (AFMD) Q2 2024 Earnings Call TranscriptSeptember 5, 2024 | seekingalpha.comAffimed Appoints Shawn M. Leland as Chief Executive OfficerSeptember 3, 2024 | globenewswire.comAffimed (AFMD) Scheduled to Post Earnings on ThursdayAffimed (NASDAQ:AFMD) will be releasing earnings before the market opens on Thursday, September 5, Zacks reports.August 30, 2024 | marketbeat.comAffimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024August 29, 2024 | globenewswire.comAffimed (NASDAQ:AFMD) Stock Price Crosses Below 200 Day Moving Average of $5.35Affimed (NASDAQ:AFMD) Share Price Passes Below Two Hundred Day Moving Average of $5.35August 24, 2024 | marketbeat.comShort Interest in Affimed (NASDAQ:AFMD) Decreases By 19.3%Affimed (NASDAQ:AFMD - Get Free Report) was the target of a significant drop in short interest in the month of July. As of July 31st, there was short interest totalling 783,900 shares, a drop of 19.3% from the July 15th total of 971,500 shares. Based on an average daily trading volume, of 694,200 shares, the short-interest ratio is presently 1.1 days. Approximately 6.0% of the company's stock are short sold.August 16, 2024 | marketbeat.comAffimed (NASDAQ:AFMD) Receives Average Recommendation of "Buy" from AnalystsShares of Affimed (NASDAQ:AFMD - Get Free Report) have received an average recommendation of "Buy" from the four analysts that are covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages thAugust 14, 2024 | marketbeat.comAFMD Aug 2024 10.000 call (AFMD240816C00010000)August 13, 2024 | finance.yahoo.comKennedy Capital Management LLC Sells 622,134 Shares of Affimed (NASDAQ:AFMD)Kennedy Capital Management LLC cut its stake in Affimed (NASDAQ:AFMD - Free Report) by 98.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,106 shares of the biopharmaceutical company's stock after sellinAugust 2, 2024 | marketbeat.comAFMD Affimed N.V.August 1, 2024 | seekingalpha.comAffimed (AFMD) to Report Q2 Earnings: What's in the Cards?July 29, 2024 | msn.comBNP Paribas Financial Markets Sells 499,391 Shares of Affimed (NASDAQ:AFMD)BNP Paribas Financial Markets decreased its position in shares of Affimed (NASDAQ:AFMD - Free Report) by 87.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 72,584 shares of the biopharmaceutical company's stock after selling 499,391 shares during the quarJuly 24, 2024 | marketbeat.comAffimed (NASDAQ:AFMD) Given Consensus Recommendation of "Buy" by BrokeragesShares of Affimed (NASDAQ:AFMD - Get Free Report) have been given a consensus rating of "Buy" by the six research firms that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have issued raJuly 20, 2024 | marketbeat.comAffimed (NASDAQ:AFMD) Short Interest Up 8.5% in JuneAffimed (NASDAQ:AFMD - Get Free Report) was the recipient of a significant growth in short interest in June. As of June 30th, there was short interest totalling 1,000,000 shares, a growth of 8.5% from the June 15th total of 921,900 shares. Approximately 7.7% of the company's stock are short sold. Based on an average trading volume of 676,200 shares, the days-to-cover ratio is currently 1.5 days.July 16, 2024 | marketbeat.comAffimed (NASDAQ:AFMD) Given New $25.00 Price Target at LaidlawLaidlaw upped their price objective on Affimed from $15.00 to $25.00 and gave the stock a "buy" rating in a research note on Thursday.June 13, 2024 | marketbeat.comAFMD Stock Earnings: Affimed Beats EPS, Misses Revenue for Q1 2024June 12, 2024 | investorplace.comAffimed Reports First Quarter 2024 Financial Results & Business UpdateJune 12, 2024 | globenewswire.com546,067 Shares in Affimed (NASDAQ:AFMD) Bought by Vestal Point Capital LPVestal Point Capital LP acquired a new position in Affimed (NASDAQ:AFMD - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 546,067 shares of the biopharmaceutical company's stocJune 9, 2024 | marketbeat.comAffimed (AFMD) Scheduled to Post Earnings on WednesdayAffimed (NASDAQ:AFMD) will be releasing earnings before the market opens on Wednesday, June 12, Zacks reports.June 6, 2024 | marketbeat.comAffimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024June 5, 2024 | globenewswire.comBNP Paribas Financial Markets Has $357,000 Stake in Affimed (NASDAQ:AFMD)BNP Paribas Financial Markets boosted its stake in shares of Affimed (NASDAQ:AFMD - Free Report) by 39.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 571,975 shares of the biopharmaceutical company's stock after buyingJune 5, 2024 | marketbeat.com Get Affimed News Delivered to You Automatically Sign up to receive the latest news and ratings for AFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here AFMD Media Mentions By Week AFMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AFMD News Sentiment▼0.420.46▲Average Medical News Sentiment AFMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AFMD Articles This Week▼152▲AFMD Articles Average Week Get Affimed News Delivered to You Automatically Sign up to receive the latest news and ratings for AFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NKTX News Today GALT News Today DMAC News Today TIL News Today MDWD News Today ADAP News Today LFVN News Today ACTU News Today TSVT News Today FULC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AFMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Affimed Please log in to your account or sign up in order to add this asset to your watchlist. Share Affimed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AFMD Stock Alerts